甲状腺功能减退症的呼吸系统表现:一项系统综述
该系统综述检索了1950年1月至2015年1月PubMed和EMBASE数据库,纳入22篇文献,旨在明确甲状腺功能减退症患者呼吸系统问题的患病率及机制。结果显示,新诊断的显性甲状腺功能减退症患者中30%存在阻塞性睡眠呼吸暂停综合征,且治疗后具有可逆性;但肺功能直接受累的证据不明确,各机制领域研究数量有限,无法得出强结论。
要点
- 新诊断显性甲状腺功能减退症患者中30%存在阻塞性睡眠呼吸暂停综合征,治疗后具有可逆性。
- 甲状腺功能减退症可能通过通气控制系统、膈肌功能、肺气体交换、甲状腺肿致上气道梗阻等多层面机制影响呼吸。
- 各机制领域研究数量有限,且多数研究存在较高偏倚风险,无法得出强结论。
核心结论
- 甲状腺功能减退症与呼吸功能相关的机制数据至多有限,该研究领域有待采用合适的研究设计和方法重新检验假说。
研究设计与样本
- 系统综述,检索PubMed和EMBASE数据库1950年1月至2015年1月的英文文献,纳入成人亚临床或显性甲状腺功能减退症患者的干预性、观察性或回顾性研究,主题为呼吸系统表现;遵循PRISMA声明,使用Cochrane偏倚风险工具;共筛选1699篇文献,22篇纳入综述。
主要发现
- 新诊断的显性甲状腺功能减退症患者中30%存在阻塞性睡眠呼吸暂停综合征,且治疗后具有可逆性。
- 已识别出多种可能解释呼吸问题的机制,涉及通气控制系统、膈肌肌肉功能、肺气体交换、甲状腺肿导致的上气道梗阻、能量转导能力下降和糖酵解活性降低。
- 关于甲状腺功能减退症对肺功能直接影响的证据不明确。
- 上述每个领域仅涉及有限数量的研究,因此无法就任何主题得出强结论。
关键数值与推荐
- 新诊断显性甲状腺功能减退症患者中阻塞性睡眠呼吸暂停综合征的患病率为30%。
局限性
- 上述每个领域仅涉及有限数量的研究,因此无法就任何主题得出强结论。
- 多数研究存在相当高的偏倚风险,例如患者数量少、缺乏对照组、随机化和盲法,以及受试者与对照者之间体重指数、性别和年龄存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypothyroidism has been associated with increased pulmonary morbidity and overall mortality. A systematic review was conducted to identify the prevalence and underlying mechanisms of respiratory problems among patients with thyroid insufficiency. METHODS: PubMed and EMBASE databases were searched for relevant literature from January 1950 through January 2015 with the following study eligibility criteria: English-language publications; adult subclinical or overt hypothyroid patients; intervention, observational, or retrospective studies; and respiratory manifestations. The Preferred Reporting Items for Systematic reviews and Meta-Analyses statement was followed, and Cochrane's risk of bias tool was used. RESULTS: A total of 1699 papers were screened by two independent authors for relevant titles. Of 109 relevant abstracts, 28 papers underwent full-text analyses, of which 22 were included in the review. Possible mechanisms explaining respiratory problems at multiple physiological levels were identified, such as the ventilator control system, diaphragmatic muscle function, pulmonary gas exchange, goiter caused upper airway obstruction, decreased capacity for energy transduction, and reduced glycolytic activity. Obstructive sleep apnea syndrome was found among 30% of newly diagnosed patients with overt hypothyroidism, and demonstrated reversibility following treatment. The evidence for or against a direct effect on pulmonary function was ambiguous. However, each of the above-mentioned areas was only dealt with in a limited number of studies. Therefore, it is not possible to draw any strong conclusions on any of these themes. Moreover, most studies were hampered by considerable risk of bias due for example to small numbers of patients, lack of control groups, randomization and blinding, and differences in body mass index, sex, and age between subjects and controls. CONCLUSION: Mechanistic data linking hypothyroidism and respiratory function are at best limited. This area of research is therefore open for retesting hypotheses, using appropriate study designs and methods.
引用
- Sorensen JR, Winther KH, Bonnema SJ, et al. Respiratory Manifestations of Hypothyroidism: A Systematic Review. Thyroid. 2016. PMID: 27673426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。